ThunderBio Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Series B3
- Latest Deal Amount
-
$17.7M
- Investors
-
16
ThunderBio General Information
Description
Manufacturer of digital PCR diagnostic systems designed to focus on the microfluidic technology in vitro diagnostic platforms. The PCR system can digitize the medical test results, and the results can be used for medication guidance or predictive treatment, etc, providing reliable digital support for medical practitioners and researchers.
Contact Information
Website
www.thunder-bio.comCorporate Office
- Floors 6 and 7 of Building 6 and Floors 6 and 7 of Building 8, Number 313 Lingxiu Road
- Luoxing Street, Jiashan County
- Jiaxing, Zhejiang 314100
- China
Corporate Office
- Floors 6 and 7 of Building 6 and Floors 6 and 7 of Building 8, Number 313 Lingxiu Road
- Luoxing Street, Jiashan County
- Jiaxing, Zhejiang 314100
- China
ThunderBio Timeline
ThunderBio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series B3) | 15-Jun-2026 | $17.7M | Completed | Generating Revenue | ||
| 7. Later Stage VC (Series B2) | 10-Oct-2025 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series B1) | 02-Jan-2024 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 23-Sep-2022 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 30-Aug-2021 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 27-Mar-2020 | Completed | Generating Revenue | |||
| 2. Seed Round | 01-Mar-2019 | Completed | Startup | |||
| 1. Accelerator/Incubator | 04-Jun-2018 | Completed | Startup |
ThunderBio Patents
ThunderBio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-D1129670-S1 | Droplet microfluidic analyzer | Active | 09-May-2024 | ||
| WO-2021147873-A1 | Method for amplifying a target nucleic acid | Inactive | 21-Jan-2020 | ||
| WO-2020078367-A1 | Pressure insensitive microfluidic circuit for droplet generation and uses thereof | Inactive | 18-Oct-2018 | ||
| WO-2020057531-A1 | Real-time monitoring of single cell or events | Inactive | 20-Sep-2018 | ||
| WO-2020043036-A1 | Co-detection and digital quantification of bioassay | Inactive | 27-Aug-2018 | C12Q1/6806 |
ThunderBio Signals
ThunderBio Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Hiway Capital | Venture Capital | Minority | ||
| Shanghai Pudong Venture Capital | Venture Capital | Minority | ||
| Shenzhen Nanshan Strategic Emerging Industry Investment | Government | Minority | ||
| Shanghai STVC Group | Growth/Expansion | Minority | ||
| BridgeOne Capital | Venture Capital | Minority |
ThunderBio FAQs
-
When was ThunderBio founded?
ThunderBio was founded in 2018.
-
Where is ThunderBio headquartered?
ThunderBio is headquartered in Jiaxing, China.
-
What is the size of ThunderBio?
ThunderBio has 14 total employees.
-
What industry is ThunderBio in?
ThunderBio’s primary industry is Diagnostic Equipment.
-
Is ThunderBio a private or public company?
ThunderBio is a Private company.
-
What is ThunderBio’s current revenue?
The current revenue for ThunderBio is .
-
How much funding has ThunderBio raised over time?
ThunderBio has raised $37.5M.
-
Who are ThunderBio’s investors?
Hiway Capital, Shanghai Pudong Venture Capital, Shenzhen Nanshan Strategic Emerging Industry Investment, Shanghai STVC Group, and BridgeOne Capital are 5 of 16 investors who have invested in ThunderBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process